For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Citizens Financial Group Inc. (CFG) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-09-21): Designation Low · Gem Score -30 (−100…+100 Quality+Value blend) · Quality 14 · Value -60 · Sentiment 24 (timing only, not weighted) · Composite fair value $56.09 vs $70.49 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Citizens Financial Group Inc.
CFG NYSECitizens Financial Group Inc. is a bank holding company that provides retail and commercial banking services across the United States. Citizens Financial Group Inc. serves individuals, small businesses, middle-market companies, corporations, and institutional clients through products and services that include deposit accounts, lending, mortgage and home equity financing, credit cards, treasury management, foreign exchange, capital markets, and wealth management. The company operates through its Consumer Banking and Commercial Banking segments, with a focus on everyday banking needs, business financing, and specialized financial solutions for larger clients. Its role in the financial market is centered on deposit gathering, credit intermediation, and fee-based banking services, making it a diversified provider of core banking and advisory offerings for both consumers and businesses.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 3.86
Total Equity: $26.32B
Shares: 474,352,332
Total Debt: $11.22B
Cash: $12.73B
EBITDA: N/A
Total Debt: $11.22B
Cash: $12.73B
Revenue: $8.25B
Revenue: $8.25B
Revenue: $8.25B
Total Equity: $26.32B
Tax Rate: 21.3%
Equity: $26.32B
Total Debt: $11.22B
Cash: $12.73B
Current Liabilities: N/A
Long-Term Debt: $11.17B
Total Debt: $11.22B
Total Equity: $26.32B
Shares: 474,352,332
Shares: 474,352,332
CapEx: $0.00
Shares: 474,352,332
Stock Price: $70.49
Net Income: $1.83B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 27, 2026 6:34am (25d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $6.6B | $8.1B | $8.2B | $7.8B | $8.2B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $2.3B | $2.8B | $3.2B | $3.0B | $3.1B |
| Operating Income | — | — | — | — | — |
| Net Income | $2.3B | $2.1B | $1.6B | $1.5B | $1.8B |
| EBITDA | — | — | — | — | — |
| EPS | $5.18 | $4.12 | $3.14 | $3.05 | $3.90 |
| EPS (Diluted) | $5.16 | $4.10 | $3.13 | $3.03 | $3.86 |
Balance Sheet (Annual)
Last updated: Aug 27, 2026 4:30am (25d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $9.2B | $10.5B | $11.6B | $10.6B | $12.7B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $188.4B | $226.7B | $222.0B | $217.5B | $226.4B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | $6.9B | $15.9B | $13.0B | $12.4B | $11.2B |
| Total Liabilities | $165.0B | $203.0B | $197.6B | $193.3B | $200.0B |
| Total Equity | $23.4B | $23.7B | $24.3B | $24.3B | $26.3B |
| Retained Earnings | $8.0B | $9.2B | $9.8B | $10.4B | $11.3B |
Cash Flow (Annual)
Last updated: Aug 27, 2026 6:34am (25d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.3B | $4.1B | $3.0B | $2.0B | $2.2B |
| Capital Expenditure | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Acquisitions (net) | -$165.0M | -$255.0M | $0 | $0 | — |
| Net Debt Issued / (Repaid) | -$1.4B | $4.9B | -$2.4B | -$1.1B | -$1.2B |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$295.0M | -$153.0M | -$906.0M | -$1.1B | -$600.0M |
| Net Change in Cash | -$3.6B | $1.4B | $1.1B | -$1.0B | $2.1B |
Growth Trends (YoY %)
Last updated: Aug 27, 2026 6:34am (25d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +21.1% | +2.1% | -5.2% | +5.8% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | -10.6% | -22.4% | -6.2% | +21.3% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Aug 27, 2026 4:30am (25d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-07-30 | $0.46 | — | — | — |
| 2026-04-30 | $0.46 | — | — | — |
| 2026-02-04 | $0.46 | — | — | — |
| 2025-10-29 | $0.46 | — | — | — |
| 2025-07-31 | $0.42 | — | — | — |
| 2025-04-30 | $0.42 | — | — | — |
| 2025-01-31 | $0.42 | — | — | — |
| 2024-10-30 | $0.42 | — | — | — |
| 2024-07-31 | $0.42 | — | — | — |
| 2024-04-30 | $0.42 | — | — | — |
| 2024-01-30 | $0.42 | — | — | — |
| 2023-10-31 | $0.42 | — | — | — |
| 2023-08-01 | $0.42 | — | — | — |
| 2023-05-02 | $0.42 | — | — | — |
| 2023-01-30 | $0.42 | — | — | — |
| 2022-11-01 | $0.42 | — | — | — |
| 2022-08-01 | $0.42 | — | — | — |
| 2022-05-02 | $0.39 | — | — | — |
| 2022-01-28 | $0.39 | — | — | — |
| 2021-10-28 | $0.39 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Not computed yetNarrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-27 06:51The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Looking at the raw quarterly print first: revenue has climbed from $1.90B (Q3 2024) to $2.28B (Q2 2026) — a clean, monotonic eight-quarter ramp of roughly 20%. Net income more than doubled from $373M in Q1 2025 to $587M in Q2 2026, with net margin expanding from 19.3% to 25.7% in five quarters. That's not a decelerating trend — the "Low Revenue Confidence (decelerating)" tag looks wrong, or is picking up sequential Q/Q ratios rather than the trajectory. TTM revenue is roughly $8.73B vs 2025 full-year $8.25B and 2024's $7.79B; TTM NI is around $2.13B, running well ahead of 2025's $1.83B. On TTM earnings, the P/E is closer to 14x than the stated 18.3x annual. That's a material anchoring problem in the synthesis.
The synthesis's $58.50 signal-adjusted fair value implies CFG deserves ~11x TTM earnings and ~0.9x book — recession-pricing for a bank showing accelerating ROE (Q2 2026 annualized ROE on $26.3B equity is ~8.9%, up from ~5.7% a year earlier). Market Forces calls the margin expansion "non-recurring" but provides no mechanism; the actual driver is almost certainly NIM normalization plus fee income leverage, and the trend has now persisted six straight quarters. Calling that non-recurring after 18 months of consistent evidence is an assertion, not analysis. The "massive insider selling" claim is also wrong on the data provided — the last ten transactions are all A-Awards (grants), not sales. Someone is confusing award vintages with dispositions.
The contrarian case is real but different from what the models articulate. First, ROA is 0.81% — mediocre for a regional bank; JPM runs ~1.3%, and peers like FITB and RF sit at 1.0-1.1%. CFG's earnings ramp is coming off a depressed 2024 base ($1.51B NI vs $2.32B in 2021), so a lot of the "growth" is mean-reversion, not compounding. Second, at 1.27x book with 8.9% ROE, the implied cost of equity math is roughly fair — you need ROE to push toward 10-11% to justify meaningful multiple expansion, and that requires either sustained NIM (rate-dependent) or CRE credit staying benign (cycle-dependent). Third, the $11.2B debt / $12.7B cash snapshot for a bank is nearly meaningless without loan book, deposit mix, and NPL disclosure — the file is thin where it matters most for a bank thesis. Fourth, dividend yield 2.6% + buybacks is fine but not a fortress-level capital return.
Net: I dissent from the synthesis's "fully priced, fair value $58.50" call. That number embeds trailing-year earnings and ignores the accelerating trajectory visible in six consecutive quarters. On TTM earnings of ~$2.13B and a defensible 13-14x multiple for a regional bank with expanding ROE, fair value sits in the $75-82 range, not $58. I also dissent from Market Forces' "value trap" framing — the margin expansion has legs measured in quarters of consistency, and the insider-selling claim is factually unsupported by the transaction list. That said, I don't think CFG is a screaming buy either: the ROA is still sub-peer, the CRE overhang is real (top bear at weight 70 is the one bear signal I take seriously), and the entire thesis rides on rate-environment durability that neither I nor the models can forecast with conviction. The bull story is mechanical, not structural — meaning re-rating potential is capped around 1.5x book absent a franchise-quality shift. Starter position at $70 makes sense if you believe NIM holds through 2026; trim into $80+ where you're paying for continued acceleration that becomes rate-dependent. The Thesis Evaluation's -14 score overweights bear scenarios that haven't shown up in the print yet — CRE losses "materializing at scale" is a hypothesis, not a data point, and Q2 2026 NI of $587M argues the opposite.
GPT Reading
Citizens is being valued like a cleaner, higher-ROE bank than the numbers actually show. The improving quarterly trend is real: revenue has risen from $1.90B in 2024-09 to $2.28B in 2026-06, and net income has climbed from $382M to $587M over that span, with net margin expanding from about 20% to 25.7%. On a trailing run-rate basis, that is roughly $8.7B-$8.9B of revenue and a little over $2.1B of earnings power, so the market cap of $29.7B implies something like 14x forward-ish earnings rather than the stated 18.3x annual P/E. Even on that kinder view, the stock is not cheap for a regional bank generating only 6.96% ROE and 0.81% ROA on the latest annual metrics. A 1.27x price-to-book multiple for a bank earning sub-7% on equity is the core mismatch here: either returns need to move materially higher and stay there, or the multiple should be lower.
The annual history reinforces that point. Revenue is basically flat over five years, moving from $8.05B in 2022 to $8.25B in 2025, and still only modestly above 2023’s $8.22B. Earnings are not compounding from a strong base; they are recovering from a weak one. Net income was $2.32B in 2021 and $2.07B in 2022, then fell to $1.61B in 2023 and $1.51B in 2024 before rebounding to $1.83B in 2025. That is not a structural grower; it is a cyclical earnings restoration story. The market seems to be capitalizing the recent quarter-to-quarter improvement as if a better steady state has been established, but the long-view data say Citizens still has not regained its prior earnings peak. If a bank hasn’t earned back its 2021-2022 profit level yet, paying above book and a mid-teens earnings multiple requires more confidence in durability than I think the record supports.
The balance sheet is not the problem in a simple solvency sense. With $12.73B of cash against $11.22B of debt and $26.32B of equity, leverage looks manageable by the limited data provided, and operating cash flow of $2.21B supports the dividend. That reduces tail-risk and helps explain why the stock has rerated. But downside protection from balance-sheet stability is different from upside justification at $70.49. For a mature regional bank, I want either a clear valuation discount or clearly superior profitability. Here, I see neither. The business is healthier than the bearish caricature of a broken regional bank, but the stock already reflects that. Fair value to me is closer to 1.0x-1.1x book, which on $26.32B of equity implies roughly $23.7B-$26.3B of market value, or about 11%-20% below the current capitalization.
The strongest counterargument is straightforward: the inflection is happening now, and the annual ROE/P/E metrics are stale. Quarterly revenue has accelerated from $1.94B in 2025-03 to $2.28B in 2026-06, while net income has gone from $373M to $587M in just five quarters. On that trajectory, annualized earnings power is already above $2.1B, which would push ROE nearer 8%-9% and make the stock look less stretched. If the bank can hold a 24%-26% margin and keep growing revenue mid-single digits, then 1.27x book is not absurd, especially with a 2.6% dividend yield and no obvious balance-sheet stress. I weigh that less heavily because banks rarely get paid for one or two strong margin quarters unless they convert them into sustained through-cycle returns, and Citizens’ five-year record still looks like flat revenue plus volatile earnings rather than a durable rerating candidate.
What would change my mind is specific evidence that the recent earnings power is durable rather than rate-cycle noise. If the next two quarters keep revenue above $2.25B and net income above $550M while annual ROE moves decisively above 9%, I would stop arguing for a discount-to-book valuation. Likewise, if 2026 full-year earnings clear roughly $2.2B-$2.3B without a deterioration in capital or liquidity, then $70 may be defensible. Conversely, any stall back toward $2.05B-$2.10B quarterly revenue or earnings slipping below $500M would confirm that the current price is capitalizing peak-ish conditions.
Grok Reading
The raw numbers show a real, multi-quarter earnings recovery that the long-run CAGRs obscure. From the $1.94B revenue / $373M NI trough in Q1 2025, Citizens has marched to $2.28B and $587M by Q2 2026, with net margin expanding from 19.3% to 25.7%. Trailing four-quarter NI now sits near $2.13B versus the $1.51B full-year 2024 print and the $1.83B 2025 annual. That is not noise: sequential revenue has risen five straight quarters and the margin grind higher is the dominant feature of the recent tape. Balance sheet is clean enough—cash $12.73B exceeds total debt $11.22B, debt-to-equity 0.43, equity $26.32B—and operating cash flow of $2.21B covers the franchise. The problem is what the market is already paying for this bounce. At $70.49 the stock trades 18.3× trailing earnings, 1.27× book and 4.05× sales while delivering only a 7.0% ROE and 0.8% ROA. For a regional bank whose five-year revenue CAGR is essentially flat at 0.1%, those multiples embed an assumption that the current 25%+ margin regime is durable rather than a rate-cycle artifact.
The prior models’ “fully priced / value trap” call is directionally right but overstates the insider signal and underweights the earnings inflection. Every one of the last ten insider prints is an A-Award grant, not open-market selling; the “massive insider selling” claim in the Market Forces layer is simply wrong on the data. Still, the valuation synthesis fair-value band of roughly $58–64 versus $70.49 is a useful anchor: the stock sits 15–20% above the composite, and recent earnings YoY of +21% is being capitalized at a multiple that leaves almost no room for the two classic regional-bank mean-reversions—deposit-cost catch-up and eventual NIM compression once the rate path turns. CRE credit risk remains the unpriced tail that every regional desk still carries as the top bear weight, and nothing in the briefing shows loan-loss reserves or NCO trends that would let me dismiss it.
The strongest counter-argument is that the market is correctly paying for a cleaned-up franchise that has already absorbed the 2023 regional scare (stock recovered from the $48 area) and is now compounding earnings at a mid-teens run-rate while throwing off a 2.6% dividend. If the last four quarters’ $2.13B NI run-rate holds and ROE drifts toward 9–10%, then 1.27× book and high-teens earnings multiples become ordinary rather than rich, and the $58–64 models look too static. Book-value support plus the net-cash tilt also caps downside relative to pure growth names. I weigh this less heavily because ROE is still only 7%, long-term revenue growth is zero, and the secondary signals (macro headwinds, lagging peers, low revenue confidence) all point the same way: the easy margin expansion is largely behind us.
I would flip constructive on a sustained ROE print above 10% with stable NIMs through two more rate cuts, or a clear 10%+ drop in the CRE watch-list that removes the credit overhang; conversely, two consecutive quarters of margin compression back below 22% or a material uptick in charge-offs would confirm the overvaluation and push me fully bearish below $60.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Citizens Financial is a mature regional bank generating $7.8B-$8.3B in revenue with net income in a $1.5B-$2.3B band over five years. Reported FCF of $2.21B in 2025 with OCF/NI of 1.47x and slightly negative accruals (-0.4% of assets) suggests earnings are cash-backed and of decent quality; the accruals score of 1 corroborates this. Diluted share count has actually declined from 513.7M in 2023 to 474.4M in 2025, indicating net buybacks are outpacing SBC - a genuine positive for a bank of this size. Profitability trajectory is the soft spot: net income fell from $2.32B (2021) to $1.51B (2024) before recovering to $1.83B (2025), so ROE has compressed through the rate cycle even as revenue held up. The Altman Z of 0.2 flagged as 'distress' is a false alarm - Z-score is not meaningful for banks whose business model is intrinsically leveraged - but it is a reminder that as a deposit-funded institution CFG carries the usual bank fragility (deposit flight, credit cycle, AOCI on securities). Liquidity metrics from the module (cash/mktcap 42.9%) similarly mis-apply to a bank where 'cash' includes reserves against deposits. Insider tape is neutral-to-mildly-negative: CEO Bruce Van Saun sold 129.4K shares for $9.3M in July, alongside token director awards and a symbolic 20-share purchase by Swift. Not a red flag, but no conviction buying either. Overall this reads as a well-run, unremarkable regional bank - competent, steady, share-count disciplined, but without evidence of a durable moat or category-leading returns.
Verify before trusting this (6)
- Commercial real estate concentration and non-performing loan trends in the 10-K
- AOCI/HTM unrealized losses on the securities portfolio and any duration mismatch
- Uninsured deposit percentage and deposit mix stability post-2023 regional bank stress
- Actual buyback authorization and pace vs SBC - confirm the share count decline is durable
- Net interest margin trajectory and deposit beta assumptions
- Reserve coverage ratio and CECL provisioning trend
The composite fair value pegs CFG at $63.86 and the signal-adjusted FV at $58.50 versus a $70.49 price, implying roughly 9-17% downside on the valuation math. The anchored-PE cross-check ($63.86) corroborates the composite, so there is no runaway method to discount here - the inputs cluster tightly below spot. For a Solid (not Exceptional) regional bank whose earnings power dropped in 2023-24 and has only partially recovered, paying a premium to the composite FV is the wrong direction of travel.
Verify before trusting this (4)
- Forward NIM guidance and deposit beta trajectory in the next print
- Net charge-off and non-performing loan trends in CRE and consumer books
- Capital return pace (buyback authorization use vs dividend) given the shrinking share count
- Any one-off items flattering recent EPS that would lower the anchored-PE fair value
CFG sits under a modestly positive sentiment tape. The regime is early risk-on (score +30) with VIX benign at 15.2, and CFG's near-market beta of 1.01 means it participates but is not amplified. Recent price action is strong (5.8% recent vs 0.1% long-term CAGR, +2.7pp over three years), which itself feeds a self-reinforcing 'quiet compounder rerating' vibe. News flow is friendly and value-oriented: a Simply Wall St style piece framing shares as 40% below fair value, coverage of a $450M efficiency program by 2028, and value-screen comparisons - all supportive, none controversial. There is no active narrative pressure here. Archetype is steady-compounder with minimal intensity and low cult coefficient, so the stock is not being pushed by a story either direction - it drifts with the regional bank complex and the rates tape. The main non-fundamental crosswind is macro: 10y at 4.64% with a barely-positive curve and market PE 25.7 keeps regional banks in the 'NIM tailwind now, NIM cliff later' frame, but that is a sector-level worry, not something actively hitting CFG's tape this week. Analyst tone implied by the news is constructive (value framing, efficiency story). Net: gentle tailwind - the tape helps, the narrative is quietly positive, nothing is actively pressing the stock down.
Verify before trusting this (4)
- Whether the risk-on regime holds beyond its 2-day age or reverses on macro data
- Any crack in the regional-bank NIM narrative (deposit beta acceleration, credit deterioration headlines)
- Analyst target revision direction into the next print
- Yield-curve steepening or bear-flattening - either shifts the regional bank tape
Elevated long rates with a modestly positive curve are the friendliest configuration for a spread lender: assets reprice up, funding costs have stabilized, and the curve finally pays for maturity transformation. That is why regional bank earnings are expanding now. The world-level risk is not demand — households and mid-market corporates are borrowing at a mature, unspectacular clip — but the rate path itself and the delayed arrival of credit normalization. Deposits have completed most of their migration to yield-bearing forms, so the acute 2023 funding shock has passed into a chronic, manageable cost. Consolidation pressure across regionals is real and CFG is scaled enough to be a participant rather than only a target. Net: a supportive but not booming backdrop where earnings growth is manufactured from balance-sheet mechanics and fee recovery, not from a growing pie.
When we made this prediction on Aug 27, 2026, CFG was $70.23. We expect it to be $65.80 by Feb 2027, and we consider it great value under $58.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 27, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.